Geode Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.56M | Buy |
|
|||||
|
2023
Q4 | $792K | Buy |
|
|||||
|
2023
Q3 | $949K | Buy |
|
|||||
|
2023
Q2 | $2.2M | Buy |
|
|||||
|
2023
Q1 | $3.23M | Buy |
|
|||||
|
2022
Q4 | $3.76M | Buy |
|
|||||
|
2022
Q3 | $9.64M | Buy |
|
|||||
|
2022
Q2 | $9.34M | Buy |
|
|||||
|
2022
Q1 | $10.7M | Buy |
|
|||||
|
2021
Q4 | $12.4M | Buy |
|
|||||
|
2021
Q3 | $13.5M | Buy |
|
|||||
|
2021
Q2 | $11.4M | Buy |
|
|||||
|
2021
Q1 | $13.3M | Buy |
|
|||||
|
2020
Q4 | $10.5M | Buy |
|
|||||
|
2020
Q3 | $4.79M | Buy |
|
|||||
|
2020
Q2 | $4.82M | Buy |
|
|||||
|
2020
Q1 | $2.89M | Buy |
|
|||||
|
2019
Q4 | $3.46M | Buy |
|
|||||
|
2019
Q3 | $1.31M | Sell |
|
|||||
|
2019
Q2 | $1.45M | Buy |
|